Novartis AG (NVS)

83.89
1.80 2.10
NYSE : Health Technology
Prev Close 82.14
Open 83.88
Day Low/High 83.57 / 84.62
52 Wk Low/High 69.18 / 99.84
Volume 1.53M
Avg Volume 1.84M
Exchange NYSE
Shares Outstanding 2.47B
Market Cap 217.73B
EPS 3.10
P/E Ratio 26.98
Div & Yield 2.01 (2.29%)
Friday Small-Cap Focus: Xoma

Friday Small-Cap Focus: Xoma

Small biotech plunged in July, but has stabilized on two key deals.

Schlumberger, Lowe’s Shares Heading Higher Says Edward Jones Strategist

Schlumberger, Lowe’s Shares Heading Higher Says Edward Jones Strategist

Underlying support for stock prices remains positive, especially if oil prices stabilize near current levels and the dollar does not rise a lot further.

J&J, Eli Lilly Healthy for Your Portfolio Says Causeway Global Manager

J&J, Eli Lilly Healthy for Your Portfolio Says Causeway Global Manager

Healthcare stocks were hit hard in the third quarter after leading the S&P 500 for the first half of the year.

Global Stocks Fall After the Federal Reserve Keeps Rates at Record Low

And four other things you need to know now.

When Eyeing Small Biotechs, Partnerships Are Huge

When Eyeing Small Biotechs, Partnerships Are Huge

Key collaboration deals with deeper-pocketed concerns can improve the odds of investment success.

Quant Picks: 4 Pharmaceutical Companies to Add to Your Porfolio

Quant Picks: 4 Pharmaceutical Companies to Add to Your Porfolio

Here are some of the best pharmaceuticals our algorithm says you should consider looking at.

Quant Picks: 3 Pharmaceutical Companies That Pay High Dividends

Quant Picks: 3 Pharmaceutical Companies That Pay High Dividends

Here are some of the best pharmaceutical companies, that pay high dividends, TheStreet Quant Ratings says you should consider looking at.

European Markets Gain as Greece Faces Sunday Debt-Deal Ultimatum

European Markets Gain as Greece Faces Sunday Debt-Deal Ultimatum

European markets rose Wednesday after European leaders gave Greece a Sunday ultimatum for a final rescue deal or face eviction from the single currency.

What's So Great About an Up Opening?

Don't rely on Europe; it's too out of sync with U.S.

You Have to Love Biotech

In this era of turmoil, investors can take comfort in this sector.

Merger Mania Benefits Mylan

Merger Mania Benefits Mylan

Whether it's acquiring or the acquired, Mylan is building shareholder value.

Rules of the Game: Portfolio Review Time

Let's take a little tour through the various equity asset classes.

Profit From the Longer Life Spans, Part 1

Profit From the Longer Life Spans, Part 1

Americans are living much longer these days -- and there are a number of ways to invest.

Riding the Coattails of Mega-Caps

A selection based on James P. O'Shaughnessy's strategy.

Budweiser and Gerber Among Larger U.S. Brands Overseas

Budweiser and Gerber Among Larger U.S. Brands Overseas

Some of the most well-known American brands aren't actually so American, after all.

What to Watch Monday, May 5: Earnings From Drug Giant Pfizer

What to Watch Monday, May 5: Earnings From Drug Giant Pfizer

Investors will be tracking Pfizer's earnings when they report first-quarter results on May 5. Expectations are for earnings of $0.55 a share on sales of $12.07 billion.

Day Ahead: Awash in Earnings

Day Ahead: Awash in Earnings

Futures point higher; blockbuster drug deal boosts European markets.

Day Ahead: Quarter Final

Day Ahead: Quarter Final

Update: Futures positive as quarter closes; J&J sells ortho unit.

Array CEO: Partnerships Smart While Cancer Drug Develops

Array CEO: Partnerships Smart While Cancer Drug Develops

Array is partnering with AstraZeneca and Novartis on a number of cancer drugs with trials soon getting underway that could transform the company by year end.

Rules of the Game: In International Waters

Rules of the Game: In International Waters

When investing beyond your own shores, choose value over growth.

Looking Across the Pond

Looking Across the Pond

Some European names look ripe for investment right now.

Early-Morning Market Look

Let's take a peek at overnight and early-morning price action in the major asset classes. Exit light Enter night Take my hand We're off to never never land. -- Metallica, "Enter Sandman" Let's take a peek at overnight and early-morning price action ...

Takeover Bait for Profitable 2013 Fishing

Takeover Bait for Profitable 2013 Fishing

Two domestic exploration and production names that scream 'buy me' are Devon and Southwestern. 

A Prescription for Election Fever

A Prescription for Election Fever

Now is the time to pop the pharmaceutical pill and buy.

UBS Posts Worse-than-Expected Q2 Profit: Hot Trends

UBS Posts Worse-than-Expected Q2 Profit: Hot Trends

A look at the day's most searched trends on the Web, including UBS after the Swiss bank posted a worse-than-expected second-quarter profit due to losses it incurred from the Facebook initial public offering.

Two Stocks Near 9-Month Consolidation

Two Stocks Near 9-Month Consolidation

IRM has been trading in a declining triangle pattern since July. Technical indications of NVS are also positive.

Amgen Founding CEO George B. Rathmann Dies: Hot Trends

Amgen Founding CEO George B. Rathmann Dies: Hot Trends

A look at the day's most searched trends on the Web, including Amgen after the passing of its founding CEO.

The Anatomy of a Head-and-Shoulders Bottom

The Anatomy of a Head-and-Shoulders Bottom

Plenty of stocks are exhibiting these formations -- here's how to tell where they'll go from here.

The Day Ahead: Selling Pressure Mounts

The Day Ahead: Selling Pressure Mounts

Indicators pointed to a not-so-super Tuesday, as international growth concerns weighed on U.S futures.